Driving engagement with HCPs
The move from paper to digital has huge cost advantages – eliminating print, warehousing and distribution as well as allowing benefits of global procurement.
Pharmaceutical companies can support their commercial and medical field force by providing them with a solution that enables them to engage with HCPs with the published scientific content that helps build trust and confidence. At the same time they can track usage of the content shared. It also allows companies to capture consent from HCPs to share ongoing digital communications.
Working with the Publishers
Publishers also benefit. We enable publishers to drive engagement with HCPs by delivering their content direct via the pharmaceutical industry, providing protection of copyright, channel access, and license management. By leveraging the pharma companies’ HCP relationships and insights, content can be delivered in line with the HCP needs, interests and delivery methods, saving them precious time and effort. Our role is to provide visibility for available content. We can also manage associated content in the same way (e.g. digital enhancers, video summaries, article summaries) and provide insight back to publisher regarding their content consumption across the globe.
Providing value for HCPs
HCPs and ultimately their patients are also indirect beneficiaries. The latest scientific research is vital in supporting clinical decision making. Removing the need to trawl through hundreds of clinical papers or get stuck in a complicated research library, means HCPs have the information they need at their fingertips fast leading to more educated prescribing decisions.